Research map: The heparan sulfate mimetic PI-88 is a potent inhibitor of HIV-1 independently of its anti-heparanase activity

Back to the article

Papers in this map

  1. Sulforhodamine B colorimetric assay for cytotoxicity screening · Vanicha Vichai · 2006 · 3736 citations · Cited by this paper
  2. Envelope protein residue E152 confers enhanced GAS6-dependent cell entry to the African Zika virus strain MR766 · 2026 · Related
  3. A diverse range of gene products are effectors of the type I interferon antiviral response · John W. Schoggins · 2011 · 2552 citations · Cited by this paper
  4. Recombinant polyclonal antibody GIGA-2339 potently and pan-genotypically neutralizes hepatitis B virus · 2026 · Related
  5. SwissDock, a protein-small molecule docking web service based on EADock DSS · Aurélien Grosdidier · 2011 · 1979 citations · Cited by this paper
  6. Fluorescence polarization–based high-throughput screening identifies SAM-competitive inhibitors of monkeypox virus N7-methyltransferase · 2026 · Related
  7. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry · J Michael Kilby · 1998 · 998 citations · Cited by this paper
  8. Human monoclonal antibodies from donors vaccinated with recombinant vaccinia vaccine targeting A35 and B6 effectively inhibit orthopoxvirus spread and infection · 2026 · Related
  9. Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis · Israël Vlodavsky · 2001 · 605 citations · Cited by this paper
  10. Nanoparticles in viral pneumonia: diagnosis, therapy, and prevention · 2026 · Related
  11. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism · Bruce W. Chesebro · 1992 · 595 citations · Cited by this paper
  12. A subset of histamine H4 receptor antagonists prevents B lymphocyte proliferation induced by BCR/TLR9 engagement or EBV infection · 2026 · Related
  13. SwissDock 2024: major enhancements for small-molecule docking with Attracting Cavities and AutoDock Vina · Marine Bugnon · 2024 · 584 citations · Cited by this paper
  14. A stapled viral peptide blocks HSV-2 from infecting human cervical cells · 2026 · Related
  15. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis · Mark D. Hulett · 1999 · 522 citations · Cited by this paper
  16. Human cytomegalovirus terminase inhibitors letermovir, tomeglovir, and the halogenated benzimidazoles modify DNA cleavage/packaging to generate a super-genomic DNA species by cleavage site skipping · 2026 · Related
  17. Dengue Virus NS1 Disrupts the Endothelial Glycocalyx, Leading to Hyperpermeability · Henry Nelson Puerta-Guardo · 2016 · 401 citations · Cited by this paper
  18. Cell-type specific effects of SARS-CoV-2 P252L mutation on nirmatrelvir sensitivity · 2026 · Related
  19. A new reporter cell line to monitor HIV infection and drug susceptibility in vitro · Alain Gervaix · 1997 · 259 citations · Cited by this paper
  20. Neutralizing antibodies as A therapy for hepatitis E virus: Advances, challenges and opportunities · 2026 · Related
  21. Heparanase: From basic research to therapeutic applications in cancer and inflammation · Israël Vlodavsky · 2016 · 245 citations · Cited by this paper
  22. The Safety, Plasma Pharmacokinetics, and Antiviral Activity of Subcutaneous Enfuvirtide (T-20), a Peptide Inhibitor of gp41-Mediated Virus Fusion, in HIV-Infected Adults · J Michael Kilby · 2002 · 200 citations · Cited by this paper
  23. Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses · Eva Lee · 2005 · 183 citations · Cited by this paper
  24. Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage · Chun‐Jen Liu · 2009 · 157 citations · Cited by this paper
  25. A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy · Jacob Paul Lalezari · 2003 · 150 citations · Cited by this paper
  26. Assembly of Infectious HIV-1 in Human Epithelial and T-Lymphoblastic Cell Lines · Boyan Grigorov · 2006 · 149 citations · Cited by this paper
  27. Heparanase is a host enzyme required for herpes simplex virus-1 release from cells · Satvik R. Hadigal · 2015 · 146 citations · Cited by this paper
  28. The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells · James H. Simon · 1997 · 146 citations · Cited by this paper
  29. Human Immunodeficiency Virus and Heparan Sulfate: From Attachment to Entry Inhibition · Bridgette J. Connell · 2013 · 144 citations · Cited by this paper
  30. Rapid Emergence of Enfuvirtide Resistance in HIV-1-Infected Patients · Jing Lü · 2006 · 113 citations · Cited by this paper
  31. The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus · Kristina Nyberg · 2004 · 107 citations · Cited by this paper
  32. HEPARANASE PROTEIN AND GENE EXPRESSION IN BLADDER CANCER · Kazuo Gohji · 2001 · 107 citations · Cited by this paper
  33. Heparanase: A Multitasking Protein Involved in Extracellular Matrix (ECM) Remodeling and Intracellular Events · Valentina Masola · 2018 · 106 citations · Cited by this paper
  34. PI-88: a novel inhibitor of angiogenesis · Ragini Reiney Kudchadkar · 2008 · 103 citations · Cited by this paper
  35. Temperature dependence of cell-cell fusion induced by the envelope glycoprotein of human immunodeficiency virus type 1 · S Frey · 1995 · 103 citations · Cited by this paper
  36. A human immune system mouse model with robust lymph node development · Yan Li · 2018 · 103 citations · Cited by this paper
  37. Hepatitis B virus-induced modulation of liver macrophage function promotes hepatocyte infection · Suzanne Faure‐Dupuy · 2019 · 103 citations · Cited by this paper
  38. A phase II study of the heparanase inhibitor PI-88 in patients with advanced melanoma · Karl D. Lewis · 2007 · 95 citations · Cited by this paper
  39. Viral Activation of Heparanase Drives Pathogenesis of Herpes Simplex Virus-1 · Alex M. Agelidis · 2017 · 89 citations · Cited by this paper

Source: OpenAlex (CC0)